RxDoctor Payments DataLook up a doctor →

Crystal Travis

Psychiatric/Mental Health · Jackson, OHNPI 1003255266

Payments from drug & device makers

$333,446in general payments, 2019–2025

Across 1,139 payments — averaging $292.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$214K
  • Axsome Therapeutics, Inc.$59K
  • E.r. Squibb & Sons, L.L.C.$47K
  • Vanda Pharmaceuticals Inc.$8K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$997
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$37,99211%
  • Speaking & faculty fees$255,10177%
  • Travel & lodging$23,2507%
  • Food & beverage$16,6315%
  • Education$4730%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$333,446 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate34$258,478
VraylarCariprazine Hcl146$159,596
AuvelityDextromethorphan Hbr/Bupropion103$126,196
CaplytaLumateperone Tosylate39$61,469
TrintellixVortioxetine Hydrobromide36$16,978
Aripiprazole53$5,267
Lurasidone Hcl38$3,584
Risperidone79$1,124
Doxepin Hcl37$1,094
Hydroxyzine Hcl58$892
Duloxetine Hcl79$815
Fluoxetine Hcl51$803
Quetiapine Fumarate20$787
Prazosin Hcl32$774
Lamotrigine106$745

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$120$258,47834 claims
AbbVieVraylar$213,819$159,596146 claims
Axsome Therapeutics, Inc.Auvelity$58,617$126,196103 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$710$61,46939 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$16$16,97836 claims
Lilly USA, LLCOlanzapine$48$32328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Jackson

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →